Trump Administration’s Operation Warp Speed Accelerates AstraZeneca COVID-19 Vaccine to be Available Beginning in October

Responding to the Administration's call to develop 300 million doses of SARS-CoV-2 vaccine by January under Operation Warp Speed, the U.S. Department of Health and Human Services (HHS) and AstraZeneca are collaborating to make available at least 300 million doses of a coronavirus vaccine called AZD1222, with the first doses delivered as early as October 2020. The agreement between AstraZeneca and the Biomedical Advanced Research and Development Authority (BARDA)will accelerate the development and manufacturing of the company’s investigational vaccine to begin Phase 3 clinical studies this summer with approximately 30,000 volunteers in the United States.